Evidence map›Paper›PMID 28398198›Full record

ArticleeLife2017

Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance.

Rachel W Anantha, Srilatha Simhadri, Tzeh Keong Foo, Susanna Miao, Jingmei Liu, Zhiyuan Shen, Shridar Ganesan, Bing Xia

Open access · goldAbstract read
In one paragraph

Article in eLife, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Proline variants in the BRCA1 coiled-coil domain disrupt folding and binding to PALB2.Protein science : a publication of the Protein Society · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Rachel W AnanthaRutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, United States.
Srilatha SimhadriRutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, United States.
Tzeh Keong FooRutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, United States.ORCID 0000-0003-0168-7054
Susanna MiaoDepartment of Genetics, School of Arts and Sciences, Rutgers, The State University of New Jersey, Piscataway, United States.
Jingmei LiuRutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, United States.
Zhiyuan ShenRutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, United States.ORCID 0000-0003-2834-0309
Shridar GanesanRutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, United States.
Bing XiaRutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, United States.ORCID 0000-0003-3259-6139
Rutgers, The State University of New Jersey · US

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Chang S Chan · 1997 to 2026
$94.5M
Role of PALB2 in the DNA Damage Response and Cancer SuppressionR01CA138804 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI XIA, BING · 2009 to 2024
$5.5M
Molecular modulators of radiation-induced chromosome instability and hematopoietic damageR01CA195612 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI SHEN, ZHIYUAN · 2015 to 2025
$3.6M
Targeting Autophagy in Hereditary Breast CancerR01CA188096 · NCI · RBHS -CANCER INSTITUTE OF NEW JERSEY · PI WHITE, EILEEN P., XIA, BING · 2015 to 2019
$2.4M
53BP1-Mediated Regulation of DNA Repair and ChemoresistanceR01CA169182 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI GANESAN, SHRIDAR · 2012 to 2016
$1.6M
Fluorescence Activated Cell SorterS10RR025468 · NCRR · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI LATTIME, EDMUND C. · 2009 to 2009
$500k
NCI NIH HHS P30 CA072720NCI NIH HHS R01 CA138804NCI NIH HHS R01 CA169182NCI NIH HHS R01 CA188096NCI NIH HHS R01 CA195612NCRR NIH HHS S10 RR025468
6 · The paper itself

Abstract

BRCA1 plays a critical role in homology-directed repair (HDR) of DNA double strand breaks, and the repair defect of

Indexed as

DNA Breaks, Double-StrandedDNA RepairAntineoplastic AgentsBase PairingBRCA1 ProteinCell Line, TumorCisplatinDrug Resistance, NeoplasmHomologous RecombinationHumansMutant ProteinsPhthalazinesPiperazinesAntineoplastic AgentsBRCA1 ProteinBRCA1 protein, humanCisplatinMutant ProteinsolaparibPhthalazinesPiperazinesBRCA1BRCA2cancer biologychromosomesgeneshomologous recombinationhumanolaparibPALB2single strand annealing

Identifiers

PMID28398198
PMCPMC5432210
OpenAlexW2606336993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.